| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/2010 | US7754768 1-(3-chloro-2-fluorobenzyl)-3-(2-hydroxyethyl)-thiourea; analgesics; gastrointestinal disorders, chronic pain, glaucoma, vision defects; rheumatoid arthritis, spondylitis, gouty arthritis, osteoarthritis, juvenile arthritis; autoimmune diseases: lupus erythematosus |
| 07/13/2010 | US7754767 Method for treatment of premature ejaculation in humans |
| 07/13/2010 | US7754766 sanitizing surfaces, living tissues, soil or atmosphere, contaminated by toxins, chemical warfare agent, insects, prions, microorganisms or other infectious agents, using an aqueous mixture of a lower alkanol, an alkalinating agent and a fatty acid salt |
| 07/13/2010 | US7754765 Copper chelators for treating ocular inflammation |
| 07/13/2010 | US7754764 Fatty acid nutritional supplement |
| 07/13/2010 | US7754763 Oral composition to reduce cold symptoms and duration of same |
| 07/13/2010 | US7754761 Sulfonated compounds and compositions for treating amyloidosis |
| 07/13/2010 | US7754760 inducing endothelium-dependent vasodilation in a human or a veterinary animal by orally administering to the human or animal in need thereof a composition comprising an effective amount of epicatechin, and/or a pharmaceutically acceptable salt thereof, in combination with a food or beverage |
| 07/13/2010 | US7754759 selective serotonin receptor antagonists, such as 7-Benzenesulfonyl-2-methylaminomethyl-chroman-4-one; treating nervous system disorders selected from psychoses, schizophrenia, depression, attention deficit disorder, amyotrophic lateral sclerosis, Parkinson's, Alzheimer's and Huntington's disease |
| 07/13/2010 | US7754758 chemokine receptor antagonists, such as 1-{3-[3-(4-fluorophenoxy)pyrrolidine-1-yl]propyl}-3-(3-methoxyphenyl)-urea, used as antiinflammatory agents |
| 07/13/2010 | US7754757 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
| 07/13/2010 | US7754756 N-(1-{3-[(R)-2-[3-(phenylsulphonylamino)-phenyl]-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-indol-5-yl)-2-cyano-acetamide, used for treating non-insulin dependent diabetes, obesity or overactive bladder |
| 07/13/2010 | US7754755 Inhibitors of 15-lipoxygenase |
| 07/13/2010 | US7754754 benzo[b]furan-2-yl-(3,5-dichlorophenylamino)acetic acid, benzo[b]thiophen-2-yl-(3,5-dichlorophenylamino)acetic acid, for example; for combatting pain, preferably chronic and/or neuropathic pain, and which preferably do not exhibit the undesired accompanying symptoms which occur with opioids |
| 07/13/2010 | US7754753 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib |
| 07/13/2010 | US7754752 Crystals of substituted phenylalkanoic acid and method of producing the same |
| 07/13/2010 | US7754751 Preferential inhibition of release of pro-inflammatory cytokines |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754749 Combating insects and/or acarids; protecting plants; such as 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-(1-methyl-2,2-dichlorocyclopropyl)-5-methyl-1,2,4-triazole |
| 07/13/2010 | US7754748 Method for treating obesity |
| 07/13/2010 | US7754746 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma |
| 07/13/2010 | US7754745 [3-(2-{(3S)-3-[2-(Trifluoromethyl)phenoxy]pyrrolidin-1-yl}-1,3-thiazol-5-yl)-1,2,4-oxadiazol-5-yl]methanol, useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disorders, atherosclerosis, obesity, diabetes and fatty liver |
| 07/13/2010 | US7754744 Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists |
| 07/13/2010 | US7754743 Heteroarylcarbamoylbenzene derivatives |
| 07/13/2010 | US7754742 such as 1-methyl-1H-imidazole-4-carboxylic acid 4-(3-hydroxy-4-isobutyryl-2-trifluoromethyl-phenoxymethyl)-benzylamide; preferential modulatators of glutamate receptors, used as antidepressants and anxiolytic agents |
| 07/13/2010 | US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora |
| 07/13/2010 | US7754740 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong |
| 07/13/2010 | US7754739 Modulators of CFTR |
| 07/13/2010 | US7754738 pyrazolecarboxanilide derivatives such as N-(2-chloro-6-methylphenyl)-1-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used for controlling pests; effective, less costly, less toxic and environmentally friendly pesticides |
| 07/13/2010 | US7754737 such as N-(1-amino-3-cyclohexylpropan-2-yl)-3-(1-hydroxy-1-phenylpentyl)piperidine-1-carboxamide, used in the treatment of cardiovascular, metabolic and cognitive disorders, aldosteronism, hypertension and anxiety |
| 07/13/2010 | US7754736 5-aminoindole derivatives as H3 inverse agonists |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening |
| 07/13/2010 | US7754733 specific crystalline polymorphic form of the pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride (or 9-dimethylaminomethyl-10-hydroxycamptothecin monohydrochloride pentahydrate) |
| 07/13/2010 | US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders |
| 07/13/2010 | US7754731 Potassium salt of an HIV integrase inhibitor |
| 07/13/2010 | US7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 07/13/2010 | US7754729 tert-butyl 4-((4-(3-ethynylphenylamino)quinazolin-6-ylcarbamoyl)methylene)piperidine-1-carboxylate, used for treating or preventing physiological disorder caused by epidermal growth factor receptor (EGFR) or ERBB/Her-2 gene overexpression in mammals; anticarcinogenic agents |
| 07/13/2010 | US7754728 Adenine compound and use thereof |
| 07/13/2010 | US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents |
| 07/13/2010 | US7754725 (2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(2-dimethylamino-ethoxy)-1,3-dihydro-isoindol-2-yl]-methanone; inhibits or modulates activity of heat shock protein Hsp90; useful for treating cancer, particularly hematopoietic tumors of lymphoid or myeloid lineage, prostate, lung, breast cancer, melanoma |
| 07/13/2010 | US7754724 such as 1-Benzyl-4-[(3,5-dimethylisoxazol-4-yl)carbonyl]piperazine, used for controlling fungi and insects; insecticides; fungicides |
| 07/13/2010 | US7754723 Therapeutic agents useful for treating pain |
| 07/13/2010 | US7754722 Piperazine derivatives and methods of use |
| 07/13/2010 | US7754721 Arylpiperazine derivatives and uses thereof |
| 07/13/2010 | US7754720 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C |
| 07/13/2010 | US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists |
| 07/13/2010 | US7754718 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester |
| 07/13/2010 | US7754717 Bis-aryl amide compounds and methods of use |
| 07/13/2010 | US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas |
| 07/13/2010 | US7754715 Sustained-release oral molsidomine composition for treating atherosclerosis |
| 07/13/2010 | US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers |
| 07/13/2010 | US7754713 such as 6-(4-Hydroxy-3,5-dimethylphenyl)-4-(7-methyl-1H-benzimidazol-2-yl)-2H-pyridazin-3-one, used as cyclin-dependent kinase inhibitors, for the treatment of cancer, in particular solid tumors or leukemia; anticarcinogenic agents |
| 07/13/2010 | US7754712 11-(4-Chloro-benzenesulfonyl)-4,5,11-triaza-tricyclo[6.2.1.02,6]undeca-2(6),3-diene; inhibit beta-amyloid peptide release or its synthesis; secretases inhibitor; neurodegenerative and neurological diseases: Alzheimer's, Parkinson's diseases, Down's syndrome, degenerative dementias |
| 07/13/2010 | US7754711 Pyridazine derivatives and their use as therapeutic agents |
| 07/13/2010 | US7754710 Noribogaine in the treatment of pain and drug addiction |
| 07/13/2010 | US7754709 Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| 07/13/2010 | US7754708 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 07/13/2010 | US7754707 Methods of treatment of chronic immune disease |
| 07/13/2010 | US7754706 Mn(III) salen complexes for the treatment of the exudative and non-exudative forms of age-related macular degeneration, diabetic retinopathy, and retinal edema |
| 07/13/2010 | US7754705 for protection against poxvirus infection or pathogenesis |
| 07/13/2010 | US7754704 administering 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol, and 4-methylstigmast-7-en-3-ol; lowering hemoglobin A1c |
| 07/13/2010 | US7754703 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol |
| 07/13/2010 | US7754702 Methods and compositions for administration of iron |
| 07/13/2010 | US7754701 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 07/13/2010 | US7754700 glutamate antagonist, cAMP stimulating agent, antioxidant, vitamin B12, transporter and surfactant; for alleviating tinnitus, Meniere's Disease and/or hearing loss |
| 07/13/2010 | US7754699 Propionic Acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-4-methyl-3-propionyloxy-tetrahydro-furan-2-ylmethyl ester; inhibit RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase |
| 07/13/2010 | US7754698 Modulation of FR-alpha expression |
| 07/13/2010 | US7754697 Control of gene expression |
| 07/13/2010 | US7754696 Application of water and organic solvent soluble Ivermectin for topical and oral use |
| 07/13/2010 | US7754695 suppressing absorption of dietary lipids and/or rise of triglycerides in the blood of a mammal, comprises administering a gallotannin or ellagitannin isolated from tea leaves; plant extracts; treatment of obesity, diabetes, hyperlipidemia, hypertension, arteriosclerosis and hypertriglyceridemia |
| 07/13/2010 | US7754694 Pyrrolo[2, 1-C][1, 4]benzodiazepine-glycoside prodrug useful as a selective anti tumor agent |
| 07/13/2010 | US7754693 Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
| 07/13/2010 | US7754684 Macromolecular platinum chelates |
| 07/13/2010 | US7754681 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond |
| 07/13/2010 | US7754679 Pharmaceutical compositions for the administration of aptamers |
| 07/13/2010 | US7754500 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 07/13/2010 | US7754256 Blend of methyl sulfonyl methane, glucosamine sulfate, chondroitin sulfate, ascorbic acid, phylloquinone, yucca powder and stabilized rice bran; for dogs |
| 07/13/2010 | US7754251 chinese herbal foot-bathing agent for treating hypertension and improving sleep quality, includes fructus leonuri 20-25%, semen ziziphi spinosae 15-20%, calcined magnetitum 17-22%, spica prunellae 15-20%, ligusticum chuanxiong hort 18-23%, and borneolum 0.7-1.2% by weight in the form of mixed powder |
| 07/13/2010 | US7754250 Drugs comprising plant extracts used for prevention amyloid formation, deposition or accumulation; amyloid fibrils, amylin fibrils, or islet amyloid fibrils or pre-deposited amyloid fibrils in type II diabetes; amyloid inhibitor |
| 07/13/2010 | US7754242 Mixture of phospholipid and leucine; supplying to lungs |
| 07/13/2010 | US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes |
| 07/13/2010 | US7754238 Delivery of microparticle-conjugated drugs for inhibition of stenosis |
| 07/13/2010 | US7754237 Transdermal thiamine insect repellant |
| 07/13/2010 | US7754236 polyester-based film substrate have specified surface roughness on the side that a drug-containing adhesive layer is laminated thereon; free from any migration of a drug into a substrate; bonding strength, no adhesive residue when peeled off skin; for narcotic analgesic fentanyl |
| 07/13/2010 | US7754230 Contacting localized fat deposits associated with cellulite in a patient with an effective amount of up to 5% deoxycholic acid or sodium salt of deoxychloic acid and an excipient; do not require surgical procedures such as liposuction; does not include phosphatidyl choline |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754223 Piscirickettsia salmonis antigens and use thereof |
| 07/13/2010 | US7754220 Continuously administering to a male animal a polypeptide havingan amino acid sequence to promote the activity of Metastin, (kisspeptin-54), an endogenous ligand for G protein-coupled receptor; promoters of fertility, ovulation; treating hormone-sensitive cancers; endometriosis; drug screening |
| 07/13/2010 | US7754214 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 07/13/2010 | US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | US7754199 Pharmaceutical compositions comprising crosslinked amine polymer with repeat units derived from polymerization of tertiary amines |
| 07/13/2010 | US7754190 Neurophysiological information from quantitative electroencephalogram (QEEG) is used as the independent variable and medication response is analyzed as the dependent variable; observing the connection between neurophysiology and the clinical outcome of treatment; pharmakinetics |
| 07/13/2010 | CA2608018C Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 07/13/2010 | CA2572498C Biphasic capsule formulation |
| 07/13/2010 | CA2567916C Method for producing antibiotic / antibiotics - particles and their use |
| 07/13/2010 | CA2567776C Vasopressin v1a antagonists |
| 07/13/2010 | CA2557536C Amino alcohol compound |
| 07/13/2010 | CA2539546C Isoquinoline potassium channel inhibitors |